We are a treatment development team. We aim to develop more effective and efficient treatments for psychiatric and psychological health problems by (a) applying a multi-systems and mechanisms-focused framework in which basic science findings on cognitive, affective, biological, behavioral and developmental contributors are used as sources for deriving novel interventions and (b) intervention research is used to develop hypotheses about and/or confirm mechanisms. We are particularly interested in severe mental illness, sleep and transdiagnostic approaches.

Treatment development teams often need to take on the challenging task of retooling in the emerging, flourishing science of dissemination and implementation (D&I) to ensure the investments made in developing new treatments can be accessed by the people who most need them. Indeed, over the past decade we have been developing expertise in D&I via an R01 treatment study based in a CMHC (RO1MH105513). Also, Dr. Harvey was very fortunate to participate in the Training Institute for Dissemination and Implementation Research in Health (TIDIRH) in 2017 conducted by the National Cancer Institute.

Our research is currently funded by the National Institute of Mental Health and National Institute of Child Health and Human Development. Dr. Harvey has published over 250 research articles and book chapters and has authored three books. Dr. Harvey is a recipient of numerous awards including from the American Association for Behavior Therapy, the Beck Institute for Cognitive Therapy and Research and NARSAD. Dr. Harvey has also been awarded an Honorary Doctorate from the University of Orebro, Sweden and is a Fellow of the Association for Psychological Science. She has served on national and international committees including the Executive Committee of the Academy of Psychological Clinical Science and the Review Committee for PCSAS.